ALMOTRIPTAN MALATE PDF

In addition, it is expected that almotriptan malate (AXERT®) is generally Trial to Evaluate the Efficacy of Almotriptan Malate (AXERT®) Milligram. Almotriptan is a headache medicine that narrows blood vessels around the brain. Almotriptan also reduces substances in the body that can. Almotriptan is a triptan drug for the treatment of migraine headaches. Almotriptan Malate, Tablet, coated, mg/1, Oral, Patriot Pharmaceuticals,

Author: Yorr Samukinos
Country: Mayotte
Language: English (Spanish)
Genre: Travel
Published (Last): 28 August 2016
Pages: 471
PDF File Size: 11.29 Mb
ePub File Size: 16.44 Mb
ISBN: 444-9-93916-447-5
Downloads: 79206
Price: Free* [*Free Regsitration Required]
Uploader: Volmaran

Almotriptan is a triptan drug for the treatment of migraine headaches. Almotriltan is in a class of medications called selective serotonin receptor agonists. It works by narrowing almotripran vessels in the brain, stopping pain signals from being sent to the brain, and stopping the release of certain natural substances that cause pain, nausea, and other symptoms of migraine.

Almotriptan does not prevent migraine attacks. Almotriptan is a selective 5-hydroxytryptamine receptor subtype agonist indicated for the acute treatment of migraine attacks with or without aura in adults. Almotriptan is not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine.

Almotriptan is an agonist for a vascular 5-hydroxytryptamine receptor subtype probably a member of the 5-HT 1D family having only a weak affinity for 5-HT 1A5-HT 5Aand 5-HT 7 receptors and no significant affinity or pharmacological activity at 5-HT 25-HT 3 or 5-HT 4 receptor subtypes or at alpha1- alpha2- or beta-adrenergic, dopamine1,; dopamine2; muscarinic, or benzodiazepine receptors.

This action in humans correlates with the relief of migraine headache. In addition to causing vasoconstriction, experimental data from animal studies show that Almotriptan also activates 5-HT almotriptann receptors on peripheral terminals of the trigeminal nerve innervating cranial blood vessels, which may also contribute to the antimigrainous effect of Almotriptan in humans.

Almotriptan binds with high affinity to human 5-HT 1B and 5-HT 1D receptors leading to cranial blood vessel constriction. Patent US, issued May 17, Drug created on June 13, Almotriptan Targets 2 Enzymes 7 Biointeractions 9. Drug Interaction R -warfarin The metabolism of R -warfarin can be decreased when combined with Almotriptan. Abacavir Almotriptan may decrease the excretion rate of Abacavir which could result in a higher serum level.

Abatacept The metabolism of Almotriptan can be increased when combined with Abatacept. Abediterol The risk or severity of hypertension can be increased when Almotriptan is combined with Abediterol.

PDR Search

Abemaciclib The metabolism of Abemaciclib can be decreased when combined with Almotriptan. Abiraterone The metabolism of Almotriptan can be decreased when combined with Abiraterone.

Acalabrutinib The metabolism of Almotriptan can be decreased when combined with Acalabrutinib. Acarbose Acarbose may decrease the excretion rate of Almotriptan which could result in a higher serum level.

Acebutolol The metabolism of Almotriptan can be decreased when combined with Acebutolol. Aceclofenac Aceclofenac may decrease the excretion rate of Almotriptan which could result in a higher serum level. Acemetacin Acemetacin may decrease the excretion rate of Almotriptan which could result in a higher serum level. Acenocoumarol The metabolism of Acenocoumarol can be decreased when combined with Almotriptan.

Acepromazine The risk or severity of adverse effects can be increased when Almotriptan is combined with Acepromazine. Aceprometazine The risk or severity of adverse effects can be increased when Almotriptan is combined with Aceprometazine. Acetaminophen The metabolism of Almotriptan can be increased when combined with Acetaminophen. Acetazolamide The risk or severity of adverse effects can be increased when Acetazolamide is combined with Almotriptan.

  BS EN 13391 PDF

Acetophenazine The risk or severity of adverse effects can be increased when Almotriptan is combined with Acetophenazine. Acetylglycinamide chloral hydrate The risk or severity of adverse effects can be increased when Almotriptan is combined with Acetylglycinamide chloral hydrate.

Acetylsalicylic acid Acetylsalicylic acid may decrease the excretion rate of Almotriptan which could result in a higher serum level. Aclidinium Almotriptan may decrease the excretion rate of Aclidinium which could result in a higher serum level. Acrivastine Almotriptan may decrease the excretion rate of Acrivastine which could result in a higher serum level.

Acyclovir Acyclovir may decrease the excretion rate of Almotriptan which could result in a higher serum level.

Adalimumab The metabolism of Almotriptan can be increased when combined with Adalimumab. Adefovir Adefovir may decrease the excretion rate of Almotriptan which could result in a higher serum level. Adefovir Dipivoxil Adefovir Dipivoxil may decrease the excretion rate of Almotriptan which could result in a higher serum level.

Almotriptan – DrugBank

Adinazolam The risk or severity of adverse effects can be increased when Adinazolam is combined jalate Almotriptan.

Adipiplon The risk or severity of adverse effects can be increased when Almotriptan is combined with Adipiplon. Adrafinil The risk or severity of hypertension can be increased when Almotriptan is combined with Adrafinil. Afelimomab The metabolism of Almotriptan can be increased when combined with Afelimomab.

Agmatine The metabolism of Agmatine can be decreased when combined with Almotriptan. Agomelatine The risk or severity of adverse effects can be increased when Almotriptan is combined with Agomelatine. Ajulemic acid The risk or severity of adverse effects can be increased when Ajulemic acid is combined with Almotriptan.

Alaproclate The risk or severity of adverse effects can be increased when Almotriptan is combined with Alaproclate. Albendazole The metabolism of Almotriptan can be decreased when combined with Albendazole. Albutrepenonacog alfa Almotriptan may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level.

Alclofenac Alclofenac may decrease the excretion rate of Almotriptan which could result in a higher serum level.

Alcuronium The risk or severity of adverse effects can be increased when Almotriptan is combined with Alcuronium. Aldesleukin The metabolism of Almotriptan can be decreased when combined with Aldesleukin.

Aldosterone The metabolism of Aldosterone can be decreased when combined almotriptaan Almotriptan. Alfaxalone The risk or severity of adverse effects can be increased when Almotriptan malxte combined with Alfaxalone. Alfentanil The metabolism of Alfentanil can be decreased when combined with Almotriptan. Alfuzosin The metabolism of Almotriptan can be decreased when combined with Alfuzosin.

Alimemazine The risk or severity of adverse effects can be increased when Almotriptan is combined with Alimemazine.

Aliskiren The risk or severity of hypertension can be increased when Almotriptan is combined with Aliskiren. Allobarbital The risk or severity of adverse effects can be increased when Almotriptan is combined with Allobarbital. Allopregnanolone The risk or severity of adverse effects can be increased when Almotriptan is combined with Allopregnanolone.

Allopurinol Allopurinol may decrease the excretion rate of Almotriptan which could result in a higher serum level. Allylestrenol Almotriptan may decrease the excretion rate of Allylestrenol which could almmotriptan in a higher serum level. Almasilate Almotriptan may decrease the excretion rate of Almasilate which could result in a higher serum level.

Alminoprofen Alminoprofen may decrease the excretion rate of Almotriptan which could result in a higher serum level. Alogliptin Almotriptan may decrease the excretion rate of Alogliptin which could result in a higher serum level.

Alosetron Mxlate risk or severity alnotriptan adverse effects can be increased when Almotriptan is combined with Alosetron. Alphacetylmethadol The risk or severity almotriptqn serotonin syndrome can be increased when Almotriptan is combined with Alphacetylmethadol. Alphaprodine The risk or severity of serotonin syndrome can be increased when Almotriptan is combined with Alphaprodine.

  BARTOK CELESTA PDF

Alprazolam The metabolism of Malte can be decreased when combined with Almotriptan. Alprenolol The risk or severity of adverse effects can be increased when Alprenolol is combined with Almotriptan. Alverine The risk or severity of adverse effects can be increased when Almotriptan is combined with Alverine.

Amantadine The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Almotriptan. Ambrisentan The metabolism of Ambrisentan can be decreased when combined with Almotriptan. Ambroxol The metabolism of Ambroxol can be decreased when combined with Almotriptan.

Amibegron The risk or severity of hypertension can be increased when Almotriptan is combined with Amibegron. Amikacin Malatr may decrease the excretion rate of Almotriptan which could result in a higher serum level. Amiloride Amiloride may increase the excretion rate of Almotriptan which could result in a lower serum level and potentially a reduction in efficacy.

Amineptine The risk or severity of serotonin syndrome can be increased when Almotriptan is combined with Amineptine. Aminoglutethimide The metabolism of Almotriptan can be increased when combined with Aminoglutethimide.

Aminophenazone Aminophenazone may decrease the excretion rate malatte Almotriptan which could result in a higher serum level. Aminophylline The metabolism of Aminophylline can be decreased when combined with Almotriptan.

Amiodarone The metabolism of Amiodarone can be decreased when combined with Almotriptan. Almotgiptan The risk or severity of adverse effects can be increased when Almotriptan is combined with Amisulpride.

Amitraz The risk or severity of hypertension can be increased when Almotriptan is combined with Amitraz. Amitriptyline The metabolism of Amitriptyline can be decreased when combined with Almotriptan. Amitriptylinoxide The risk or severity of serotonin syndrome can be increased when Almotriptan is combined with Amitriptylinoxide.

Amlodipine The metabolism of Almotriptan can be decreased when combined with Amlodipine. Almtriptan chloride Almotriptan may decrease the excretion rate of Ammonium chloride which could result in a higher serum level. Amobarbital The almotripan or severity of adverse effects can be increased when Almotriptan is combined with Amobarbital. Amodiaquine The metabolism of Almotriptan can be decreased when combined with Amodiaquine. Amoxapine The metabolism of Amoxapine can be decreased when combined with Almotriptan.

Amoxicillin Almotriptan may decrease the excretion rate of Amoxicillin which could result in a higher serum level. Amperozide The risk or severity of adverse effects can be increased when Almotriptan is combined with Amperozide. Amphetamine The risk or severity of serotonin syndrome can be increased when Amphetamine is combined with Almotriptan.

Amphotericin B Amphotericin B may decrease the excretion rate of Almotriptan which could result in a higher serum level. Ampicillin Ampicillin may decrease the excretion rate of Almotriptan which could result in a higher serum level.

Amprenavir The metabolism of Almotriptan can be decreased when combined with Amprenavir. Amrinone Almotriptan may decrease the excretion rate of Amrinone which could result in a higher serum level.

Anakinra The metabolism of Almotriptan can be increased when combined with Anakinra. Anastrozole The metabolism of Almotriptan can be decreased when combined with Anastrozole.